Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7689526rdf:typepubmed:Citationlld:pubmed
pubmed-article:7689526lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:7689526lifeskim:mentionsumls-concept:C0019163lld:lifeskim
pubmed-article:7689526lifeskim:mentionsumls-concept:C0369335lld:lifeskim
pubmed-article:7689526lifeskim:mentionsumls-concept:C0860069lld:lifeskim
pubmed-article:7689526lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:7689526pubmed:issue3lld:pubmed
pubmed-article:7689526pubmed:dateCreated1993-9-27lld:pubmed
pubmed-article:7689526pubmed:abstractTextApproximately 90% of subjects with chronic hepatitis resulting from hepatitis C virus infection have hepatitis C virus RNA in serum. However, the prevalence of hepatitis C virus RNA in serum from subjects with hepatitis C virus antibody associated with persistent normal liver biochemical values is unclear. Do these subjects have resolved or continuing infection with hepatitis C virus? The aim of this study was to examine whether subjects with hepatitis C virus antibody but normal ALT levels had evidence of ongoing infection. Our study population was divided into four groups. Groups 1, 2 and 3 comprised hepatitis C virus antibody-positive volunteer blood donors. Group 1 was made up of subjects found to be hepatitis C virus antibody-positive on enzyme-linked immunosorbent assay with persistent abnormal ALT levels (59 donors: 53 positive on recombinant immunoblot assay and 6 indeterminate). Group 2 members were hepatitis C virus antibody positive, with persistent normal ALT levels (50 donors: 39 positive on recombinant immunoblot assay and 11 indeterminate). Group 3 members were hepatitis C virus seropositive but negative on second-generation recombinant immunoblot assay (n = 48). Twenty patients (not blood donors) with chronic liver disease who were anti-hepatitis C virus seronegative were used as controls (group 4). Serum samples from all four groups were assayed for hepatitis C virus RNA on reverse transcription and a 40-cycle polymerase chain reaction with a combination of primers from the highly conserved 5'-noncoding and less-conserved third and fourth nonstructural regions. All assays were confirmed on hybridization with an internal probe.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:7689526pubmed:languageenglld:pubmed
pubmed-article:7689526pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689526pubmed:citationSubsetIMlld:pubmed
pubmed-article:7689526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689526pubmed:statusMEDLINElld:pubmed
pubmed-article:7689526pubmed:monthSeplld:pubmed
pubmed-article:7689526pubmed:issn0270-9139lld:pubmed
pubmed-article:7689526pubmed:authorpubmed-author:ParsonsCClld:pubmed
pubmed-article:7689526pubmed:authorpubmed-author:BishopG AGAlld:pubmed
pubmed-article:7689526pubmed:authorpubmed-author:McCaughanG...lld:pubmed
pubmed-article:7689526pubmed:authorpubmed-author:WilesDDlld:pubmed
pubmed-article:7689526pubmed:authorpubmed-author:McGuinnessP...lld:pubmed
pubmed-article:7689526pubmed:authorpubmed-author:LiemBBlld:pubmed
pubmed-article:7689526pubmed:issnTypePrintlld:pubmed
pubmed-article:7689526pubmed:volume18lld:pubmed
pubmed-article:7689526pubmed:ownerNLMlld:pubmed
pubmed-article:7689526pubmed:authorsCompleteYlld:pubmed
pubmed-article:7689526pubmed:pagination485-90lld:pubmed
pubmed-article:7689526pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:meshHeadingpubmed-meshheading:7689526-...lld:pubmed
pubmed-article:7689526pubmed:year1993lld:pubmed
pubmed-article:7689526pubmed:articleTitleDetection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.lld:pubmed
pubmed-article:7689526pubmed:affiliationA.W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown NSW, Australia.lld:pubmed
pubmed-article:7689526pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7689526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7689526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7689526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7689526lld:pubmed